Allogeneic cell therapies “poised for prime time” says expert
While the allogeneic vs autologous debate continues in the cell therapy field, research on in vivo therapies is drawing ...
ExtremeTech on MSN2d
New Gene Therapy Cures Man's Sickle Cell Anemia
Credit: Artur Plawgo / Science Photo Library via A 21-year-old man has become the first person in New York—and ...
Devdiscourse2d
Breakthrough Gene Therapy: A New Hope for Cancer Patients
An indigenously developed CAR T-cell gene therapy has achieved a 73% response rate for certain blood cancers in India. The ...
Breakthrough gene therapy alleviates Dravet syndrome symptoms in mice without side effects
In a groundbreaking advancement for families grappling with the challenges of Dravet syndrome, a rare and life-altering form ...
Man Cured Of Sickle Cell Disease In New York Thanks To New Gene Therapy
NY resident Sebastien Beauzile was treated with a pioneering new gene therapy approach called Lyfgenia, curing his sickle ...
The Punch on MSN2d
Gene therapy delivers alternative sickle cell cure in US
Sebastien Beauzile from Laurelton, Long Island, has become the first person in New York State to be cured of sickle cell ...
BioPharma Dive2d
AstraZeneca adds ‘in vivo’ cell therapy capabilities with EsoBiotech deal
The pharma is paying up to $1 billion to buy the Belgian startup, whose technology it sees as useful in treating cancer and ...
Fierce Biotech2d
Orca's cell therapy trounces traditional care in blood cancer phase 3, swimming into space's 'holy grail'
In a late-stage trial of patients with multiple types of blood cancer, Orca Bio’s allogeneic T-cell immunotherapy doubled the ...
Long Island patient gets breakthrough sickle cell treatment called a ‘cure’: ‘I’m not in pain anymore’
A young man from Laurelton is the first New Yorker with sickle cell disease to receive Lyfgenia, a life-changing gene therapy treatment that has wiped away the debilitating illness, The Post first ...
Sickle cell anemia patient reunites with Long Island doctors whose gene therapy treatments made him symptom-free
Sebastien Beauzile, 21, became the first person in New York state to be made symptom-free of sickle cell disease after ...
Gene therapy for blood cancer shows 73 per cent response rate in clinical trials: Lancet study
A new study published in The Lancet Haematology journal says that an indigenously developed gene therapy for certain blood ...